Search Results 111-120 of 16598 for Nizatidine

  1. Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia - Mayo Clinic

    Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells or stopping them from ...

  2. https://www.mayoclinic.org/spanish_organization_concepts.xml

  3. Consumer health Medications - Mayo Clinic

    Consumer health basics. Can you remember how you got health information before the internet? Your doctor was probably your only trusted source.

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  5. Chronic kidney disease - Doctors and departments - Mayo Clinic

    Learn about kidney failure symptoms, tests, diagnosis and treatment options, including medication, dialysis and kidney transplant.

  6. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. Head and neck cancers - Doctors and departments - Mayo Clinic

    This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

  9. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  10. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

    ... nizatidine, ranitidine) within 2 days prior to the start of study therapy. Concurrent participation in another therapeutic clinical trial. Any illness ...